Heba Ali Hassan

12PUBLICATIONS
28CO-AUTHORS
Biomolecular modelling and designCheminformatics and quantitative structure-activity relationshipsMedical molecular engineering of nucleic acids and proteinsBiologically active moleculesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 16, 2023
Unraveling effective extracellular signal-regulated kinase 2 inhibitors: a de novo drug design strategy enhanced by in-depth in silico analyses.

Heba Ali Hassan, Sara S Muhammed, Ahmad Al-Khdhairawi

|Jul 21, 2023
Exploring the therapeutic potential of galidesivir analogs against Zaire ebolavirus protein 24 (V24): database screening, molecular docking, drug-relevant property evaluation and molecular dynamics simulations.

Heba Ali Hassan, Sayed F Abdelwahab, Ahmad Al-Khdhairawi

|Feb 22, 2023
In silico prediction of potential inhibitors for SARS-CoV-2 Omicron variant using molecular docking and dynamics simulation-based drug repurposing.

Eslam A R Mohamed, Islam M Abdel-Rahman, Magdi E A Zaki

|Nov 11, 2022
A Comprehensive In Silico Study of New Metabolites from Heteroxenia fuscescens with SARS-CoV-2 Inhibitory Activity.

Fahd M Abdelkarem, Alaa M Nafady, Ahmed E Allam

|Oct 26, 2022
Targeting Natural Plant Metabolites for Hunting SARS-CoV-2 Omicron BA.1 Variant Inhibitors: Extraction, Molecular Docking, Molecular Dynamics, and Physicochemical Properties Study.

Heba Ali Hassan, Ahmed R Hassan, Eslam A R Mohamed

|Sep 30, 2022
Identification of promising anti-EBOV inhibitors: de novo drug design, molecular docking and molecular dynamics studies.

Eslam A R Mohamed, Sayed F Abdelwahab, Ahmad M Alqaisi

Pageof 2

Frequent Collaborators

5 joint publications

Ahmed E Allam

4 joint publications

Ahmad Al-Khdhairawi

4 joint publications

Eslam A R Mohamed

3 joint publications

Iman A M Abdel-Rahman